LRRC31: A Potential Drug Target for Cancer (G79782)

Target Name: LRRC31

NCBI ID: G79782

LRRC31

LRRC31: A Potential Drug Target for Cancer

LRRC31, also known as Leucine rich repeat containing 31, is a protein that is expressed in various tissues throughout the body. It is a highly conserved protein that is found in all eukaryotic cells, including humans. LRRC31 is characterized by a unique repeat sequence, Known as a leucine rich repeat, which is composed of 31 amino acids.

The LRRC31 protein is involved in a variety of cellular processes, including cell signaling, DNA replication, and chromatin structure. It is also involved in the regulation of cellular processes that are important for the development and progression of cancer.

Recent studies have identified LRRC31 as a potential drug target for the treatment of various diseases, including cancer. LRRC31 has also been shown to be a potential biomarker for cancer diagnosis and prognosis.

One of the reasons for the potential of LRRC31 as a drug target is its unique structure. The LRRC31 protein is composed of a long, single-stranded protein that is rich in leucine residues. This structural feature makes it a potential target for small molecules that can modulate the activity of the protein.

In addition, LRRC31 is involved in a variety of cellular processes that are important for the development and progression of cancer. For example, LRRC31 has been shown to be involved in the regulation of the G1/S checkpoint, a critical checkpoint that helps ensure that cells are able to properly divide and grow.

LRRC31 has also been shown to be involved in the regulation of DNA replication, which is a critical process that is important for the development and progression of cancer. LRRC31 has also been shown to play a role in the regulation of DNA replication by allowing the replication machinery to access the replication start site.

In addition to its role in cell signaling and DNA replication, LRRC31 is also involved in the regulation of chromatin structure. This is important because chromatin structure is closely linked to the regulation of gene expression, which is a critical process that is important for the development and progression of cancer.

LRRC31 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of cancer. For example, LRRC31 has been shown to play a role in the regulation of the Notch signaling pathway, which is involved in the regulation of cell proliferation and survival.

In conclusion, LRRC31 is a protein that is characterized by a unique leucine rich repeat and is involved in a variety of cellular processes that are important for the development and progression of cancer. Its unique structure and involvement in important cellular processes make it a potential drug target and a potential biomarker for cancer diagnosis and prognosis. Further research is needed to fully understand the role of LRRC31 in cancer and to develop effective treatments.

Protein Name: Leucine Rich Repeat Containing 31

The "LRRC31 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC31 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets